New pill shows promise for severe eczema sufferers
NCT ID NCT06996912
First seen Jan 07, 2026 · Last updated May 25, 2026 · Updated 19 times
Summary
This study tests a new tablet called HSK44459 in 150 adults with moderate-to-severe atopic dermatitis (eczema). Participants take the tablet for 12 weeks to see if it reduces skin redness, itching, and rash. The goal is to find a safe and effective way to ease symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Affiliated Dermatology Hospital of Shandong First Medical University
Jinan, Shandong, 250022, China
Conditions
Explore the condition pages connected to this study.